These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30577849)

  • 1. Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac.
    Tian P; Zhu Y; Zhang C; Guo X; Zhang P; Xue H
    BMC Cancer; 2018 Dec; 18(1):1286. PubMed ID: 30577849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer.
    Li YH; Li YX; Li M; Song SW; Ge Y; Jin JY; Li XY; Tan XD; Ye J
    Life Sci; 2020 Sep; 256():117936. PubMed ID: 32531376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-Ras-PI3K regulates H3K56ac through PCAF to elevate the occurrence and growth of liver cancer.
    Gao X; Cheng Z; Yuan H; Zhao H
    J Cell Physiol; 2020 Apr; 235(4):3905-3915. PubMed ID: 31642074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1.
    Zhang J; Liu M; Liu W; Wang W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1207-1215. PubMed ID: 30942624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3
    Cheng Z; Li X; Hou S; Wu Y; Sun Y; Liu B
    Pharm Biol; 2019 Dec; 57(1):701-709. PubMed ID: 31613681
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinogenic role of K-Ras-ERK1/2 signaling in bladder cancer via inhibition of H1.2 phosphorylation at T146.
    Fan L; Wang Y; Wang W; Wei X
    J Cell Physiol; 2019 Nov; 234(11):21135-21144. PubMed ID: 31032946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.
    Wei Y; Wang F; Sang B; Xu Z; Yang D
    Life Sci; 2019 May; 225():55-63. PubMed ID: 30946839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras-ERK1/2 down-regulates H2A.X
    Dong C; Sun J; Ma S; Zhang G
    BMC Cancer; 2019 May; 19(1):530. PubMed ID: 31151422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras-ERK1/2 Signaling Promotes The Development Of Osteosarcoma By Regulating H2BK12ac Through CBP.
    Xu X; Yu H; Xu Y
    Cancer Manag Res; 2019; 11():9153-9163. PubMed ID: 31695502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF.
    Pan B; Liu C; Su J; Xia C
    Cell Commun Signal; 2024 Jun; 22(1):306. PubMed ID: 38831454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Ras-ERK1/2 signaling promotes the development of uveal melanoma by downregulating H3K14ac.
    Li Y; Sun W; Sun D; Yin D
    J Cell Physiol; 2019 Sep; 234(9):16011-16020. PubMed ID: 30770563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-Ras
    Zhang J; Liu W; Dong H; Wang W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2048-2057. PubMed ID: 31126199
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE‑induced cardiomyocyte hypertrophy.
    Mao Q; Wu S; Peng C; Peng B; Luo X; Huang L; Zhang H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.
    Li Y; Yu P; Zou Y; Cai W; Sun W; Han N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4257-4265. PubMed ID: 31736361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-AKT signaling represses the phosphorylation of histone H1.5 at threonine 10 via GSK3 to promote the progression of glioma.
    Sang B; Sun J; Yang D; Xu Z; Wei Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2882-2890. PubMed ID: 31307224
    [No Abstract]   [Full Text] [Related]  

  • 16. RETRACTED: Ras-ERK1/2 signaling accelerates the progression of colorectal cancer via mediation of H2BK5ac.
    Jia H; Xu M; Bo Y; Li W; Zhou R
    Life Sci; 2019 Aug; 230():89-96. PubMed ID: 31129138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21
    Oh SJ; Lee MG; Moon JR; Lee CK; Chi SG; Kim HJ
    J Gastroenterol Hepatol; 2019 May; 34(5):890-898. PubMed ID: 30226276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
    Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
    Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.
    Bjeije H; Soltani BM; Behmanesh M; Zali MR
    Hum Mol Genet; 2019 Oct; 28(19):3219-3231. PubMed ID: 31238337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ras-ERK signaling pathway regulates acetylated activating transcription factor 2 via p300 in pancreatic cancer cells.
    Li M; Song SW; Ge Y; Jin JY; Li XY; Tan XD
    Ann Transl Med; 2020 Oct; 8(19):1234. PubMed ID: 33178766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.